Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Addition of the Rhamnose (6-Deoxy-L-mannose)-rich polysaccharide, RROP-1, to normal human dermal fibroblasts (NHDFs) and human endothelial cells produced a dose-dependent stimulation of the calcium-signaling pathway, inducing fast and transient increases in Ca2 influx and intracellular free Ca2 level.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | In stock | $ 39.00 | |
500 mg | In stock | $ 91.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 30.00 |
Description | Addition of the Rhamnose (6-Deoxy-L-mannose)-rich polysaccharide, RROP-1, to normal human dermal fibroblasts (NHDFs) and human endothelial cells produced a dose-dependent stimulation of the calcium-signaling pathway, inducing fast and transient increases in Ca2 influx and intracellular free Ca2 level. |
Source |
Synonyms | 6-Deoxyhexopyranose, 6-Deoxy-L-mannose, alpha-L-Rhamnose |
Molecular Weight | 164.16 |
Formula | C6H12O5 |
CAS No. | 3615-41-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (137.06 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rhamnose 3615-41-6 Membrane transporter/Ion channel Metabolism Calcium Channel Endogenous Metabolite L-Rhamnose Inhibitor cancer immunotherapies a-L-Rhamnose monosaccharide inhibit 6-Deoxyhexopyranose α-L-Rhamnose 6-Deoxy-L-mannose alpha-L-Rhamnose inhibitor